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Adequate thyroid functioning during preg-
nancy is a known determinant of healthy
pregnancy outcomes and successful brain
development in the fetus (LaFranchi et al.
2005). Recent epidemiologic studies have
focused on subclinical maternal thyroid deﬁ-
ciency during pregnancy, particularly for
hypothyroxinemia in early gestation, and its
long-term effects on psychomotor develop-
ment in children (Pop et al. 2003). These
effects could be mediated by impaired glucose
metabolism in fetal brain during the critical
period of neuroblast proliferation (Pickard
et al. 1999). In addition, the trophoblast has
a high binding capacity for triiodothyronine
(T3), and it has been suggested that the pla-
centa is a thyroid hormone (TH)–dependent
tissue (Kilby et al. 1998; Oki et al. 2004).
Experimental studies have shown that
polychlorinated biphenyls (PCBs) and
related chemicals decrease circulating THs
during development (Donahue et al. 2004;
Ulbrich and Stahlmann 2004; Zoeller et al.
2000). Prenatal or postnatal exposition of
humans or animals to PCBs can result in hor-
monal changes and neurodevelopmental
deﬁcits (Jacobson and Jacobson 2002, 2003;
Vreugdenhil et al. 2002a, 2002b, 2004). In
rats, Goldey et al. (1995) reported that oto-
toxic effects of PCBs were associated with
decreased circulating THs after perinatal
exposure. It has also been suggested that
interference with endocrine systems, particu-
larly the thyroid, could be one possible expla-
nation for PCB-induced psychomotor delay
observed in several cohort studies (Winneke
et al. 2002).
Two classes of PCB metabolites are formed
from PCB biotransformation: hydroxylated
(OH-PCBs) and methyl sulfone PCBs. No
data are available about human exposure to
methyl sulfone PCBs or their effects on thyroid
status in experimental animals. However, most
PCB congeners and hydroxylated PCBs, which
disrupt TH status, are transferred across the
placenta to the fetus in concentrations resulting
in levels of approximately 50% and 30%,
respectively, of those in maternal plasma
(Soechitram et al. 2004). Hydroxylated PCBs
show high binding affinity for the serum
TH-binding protein transthyretin, thus displac-
ing the natural ligand, thyroxin (T4; Cheek
et al. 1999). PCBs, as well as some other
organochlorine compounds (OCs) such as
hexachlorobenzene, are also known to increase
the activity of hepatic drug-metabolizing
enzymes, in particular, uridine diphospho-
glucuronosyl transferase (UDPGT), responsible
for glucuronidation of T4 (Van Birgelen et al.
1995; van Raaij et al. 1993). In vitro, hydroxy-
lated PCBs have a low afﬁnity for the human
thyroid receptor but do have a TH-like afﬁnity
for the serum transport protein transthyretin
(Cheek et al. 1999; Meerts et al. 2002) and
inhibit the iodothyronine sulfotransferase
activity (Schuur et al. 1998).
Chlorine substitution in the phenyl rings
gives each PCB its own target and mechanism
of toxicity. “Coplanarity” of PCB phenyl rings
and “laterality” of chlorine atoms are impor-
tant structural features that determine speciﬁc
binding behavior with proteins and certain
adverse responses in biologic systems. There is
evidence that coplanar PCB mutagenic toxicity
is mediated through the aryl hydrocarbon (Ah)
receptor (Safe 1994). Recently, it was reported
that both mono-ortho and non-coplanar types
of PCBs, and hydroxylated PCB metabolites
may disrupt TH status, in part, by affecting
thyroid hormone receptor (TR)-mediated
transcription, which may inﬂuence growth and
development of TH target organs, particularly
in the central nervous system (Iwasaki et al.
2002). Khan and Hansen (2003) suggest that
non-coplanar congeners interfere with the
hypothalamo-pituitary-thyroid (HPT) axis
by producing a subnormal response of the
pituitary and thyroid to thyrotropin releasing
hormone (TRH) stimulation. 
The developing fetus is particularly
susceptible to thyrotoxic effects of PCBs and
their metabolites. In rats, exposure to hydrox-
ylated PCB 4´-OH-CB-108 from gestational
day (GD)10 to GD16 decreased maternal,
fetal, and neonatal plasma total T4 and free
T4 (fT4) in a dose-dependent manner (Meerts
et al. 2002). Chronic developmental exposure
to Aroclor 1254 from GD6 to postpartum
day 21 also reduces circulating levels of total
T4 (Zoeller et al. 2000). At the same condi-
tions of exposure, Goldey et al. (1995)
observed decreased total T4 levels and a mod-
erate reduction of T3 levels in offspring at
high doses of exposure.
Other environmental pollutants, such as
pesticides and mercury, may also disrupt thy-
roid function (Beard and Rawlings 1999;
Ellingsen et al. 2000; Rathore et al. 2002;
Watanabe et al. 1999). Long-term workplace
exposure to Hg interferes with thyroid
metabolism by reducing T4 deiodination
(Ellingsen et al. 2000). In a community highly
exposed to hexachlorobenzene, a significant
positive association was found between this
OC and concentrations of thyroid-stimulating
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Polychlorinated biphenyls (PCBs), chlorinated pesticides, and mercury are global environmental
contaminants that can disrupt the endocrine system in animals and humans. However, there is lit-
tle evidence that they can interfere with endocrine status in pregnant women and neonates at low
levels of exposure. The aim of this study was to examine thyroid hormone levels during pregnancy
and in cord blood in relation to blood concentrations of organochlorine compounds (OCs) and
Hg in healthy women recruited during pregnancy. We found a significant negative correlation
between maternal total triiodothyronine levels and three non-coplanar congeners (PCB-138,
PCB-153, and PCB-180), three pesticides (p,p´-DDE, cis-nanochlor, and hexachlorobenzene), and
inorganic Hg independently, without any other changes in thyroid status. No signiﬁcant relation-
ships were observed between OCs and cord serum thyroid hormones. Cord serum free thyroxin
was negatively correlated with inorganic Hg. These results suggest that at even low levels of expo-
sure, persistent environmental contaminants can interfere with thyroid status during pregnancy.
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Researchhormone (TSH) at birth (Ribas-Fito et al.
2003).
The general population is exposed to
multiple environmental contaminants at rela-
tively low doses, but few studies have reported
thyroid status in pregnancy in relation to mix-
tures of environmental organic pollutants.
Moreover, most studies report the sum of
PCBs (ΣPCB) as an exposure measure, which
can mask the speciﬁc effect of different groups
of congeners with different mechanism of
action. Thus, the objective of the present
study was to examine the relation between
exposure to potential endocrine-disrupting
chemicals (coplanar and non-coplanar PCBs,
organochloride pesticide residues, and Hg)
and thyroid status in pregnant women and
the newborn.
Materials and Methods
Study population. The women participating
in the study were recruited at their ﬁrst prena-
tal visit at the Centre for Local Community
Services (part of the National Public Health
System) in Southwest Québec. After signing a
consent form, each woman ﬁlled out an inter-
view-administered questionnaire, which con-
tained general sociodemographic data and
information on residency, medical history,
drinking and smoking habits, and diet, and
blood samples were obtained. Those who
were recruited into the study during the ﬁrst
trimester (before the 13th week) provided a
ﬁrst sample at entry and a second during the
second trimester, whereas those who were
recruited between the 14th and 24th weeks
provided one sample before delivery. The ﬁrst
trimester sampling was performed before the
ﬁrst ultrasound examination. The gestational
age at sampling was revised according to
ultrasound data for 22 women, who provided
two samples at the second trimester. The
study population consisted of 149 pregnant
women, 101 of whom gave birth at the par-
ticipating hospital where maternal and cord
blood samples and placental tissue were
obtained at delivery. Two weeks after birth, a
second questionnaire was interview adminis-
tered. This second questionnaire included
information on medical and obstetrical his-
tory, birth data, and smoking and drinking
during pregnancy.
After verification, only 40 women had
entered the study during the ﬁrst 13 weeks of
pregnancy, and 109 entered at the second
trimester. Thus, most data were available for
the second trimester (n = 149). At delivery,
there were 101 maternal and 92 cord blood
samples available for analyses. Thus, complete
data throughout pregnancy were available for
38 women, and for 101 from the second
trimester and at delivery. Data for hormones
and contaminants are missing for some
women (n = 2–4) because of insufficient
quantity of blood or nonrespect of specimen
storage protocol.
Biologic sampling. Blood samples for the
ﬁrst and second trimesters were collected at the
pregnant women’s residences after night fast-
ing, whereas the third-trimester samples and
cord blood samples were taken at the hospital
at delivery. Whole blood and serum samples
were refrigerated at –20°C until contaminant
and hormone determination (3–4 months).
PCBs, pesticides, and Hg determination.
Laboratory analyses of PCBs and chlorinated
pesticides were performed by the Centre of
Toxicology of Québec by gas chromatography
coupled with mass detection using a chromato-
graph (model 6890) and mass detector (model
5973) from Agilent (Mississauga, Canada).
Blood plasma (2 mL) was extracted using an
ammonium sulfate/ethanol/hexane mixture,
cleaned up on Florisil columns, and taken to a
final volume of 100 µL. Routine checks of
accuracy and precision were performed using
reference materials from the National Institute
of Standards and Technology (Gaithersburg,
MD, USA). Also, periodic evaluations were car-
ried out through participation in two external
proﬁciency testing programs [Artic Monitoring
Assessment Program ring test; Laboratoire de
toxicologie humaine/Institut national de santé
publique (INSPQ) and the German Society of
Occupational and Environmental Medicine,
Erlangen, Germany]. The detection limits
were 0.02 µg/L for PCB congeners and chlori-
nated pesticides.
Cold vapor atomic absorption spectro-
metry was used to assess total Hg (THg)
and inorganic Hg (IHg) using a mercury mon-
itor (model 100; Pharmacia Instruments,
Piscataway, NJ, USA). Organic Hg (OHg) was
calculated as the difference between THg and
IHg. THg was determined using 500 µL blood
digested with an equal volume of concentrated
nitric acid. An aliquot of the digest was then
introduced in the system’s reaction chamber
(containing a reducing solution of cadmium
chloride and stannous chloride). Hg vapor was
generated and detected, and aqueous calibra-
tion was performed. The IHg fraction was
determined using the same methodology
except that cadmium chloride was omitted
from the reactant mixture. Routine checks of
accuracy and precision were performed using
reference material from the Laboratoire de
toxicologie humaine/INSPQ’s interlaboratory
comparison program. In addition, periodic
evaluations were carried out through participa-
tion in the same program. The detection limit
obtained was 2 nmol/L (0.2 µg/L). Variation
coefﬁcients (n ~ 20, different days) at levels of
38 nmol/L IHg and 82 nmol/L OHg were 4
and 3.4%, respectively. 
The detection limits were determined from
the analyses of 10 actual samples, whose con-
centrations were between 4 and 10 times the
estimated detection limit. The standard devia-
tion of these 10 samples multiplied by 3 pro-
vided the detection limit, which was multiplied
by 10 to provide the quantiﬁcation limit.
Lipid determination. Total and free choles-
terol, triglycerides, and phospholipids were
individually measured using enzymatic meth-
ods on the Technicon automatic analyzer
(model RA-500; Technicon, Cranesville, PA,
USA) as previously described (Moorjani et al.
1987). Plasma total lipids were calculated using
the summation method: total lipids = 1.677
(total cholesterol – free cholesterol) + free cho-
lesterol + triglycerides + phospholipids.
Thyroid hormone determination. Thyroid
hormones [TSH, total T3 (TT3), and fT4]
were analyzed by radioimmunoassay at the
Clinical Biochemistry Service of Saint-
François d’Assise hospital (Québec, Canada)
(Forest et al. 1998).
Statistical analysis. All statistical analyses
were performed using SAS (version 8.12; SAS
Institute 1999). The log-normally distributed
data were log-transformed in order to use para-
metric tests. The stepwise procedure was used
to test relationships between variables of inter-
est and potential cofactors such as maternal
age, smoking and alcohol consumption, child’s
sex and birth weight (for cord blood variables),
gestational age at sampling, and total lipid con-
centrations. The relation between exposure
variables and effect variables was examined by
longitudinal repeated measure analysis (Mixed
procedure) considering the within-subject
effect and compound symmetry covariance
structure. Relationships between cord blood
exposure and effect variables were tested using
analysis of covariance (general linear model
procedure). Because a large number of samples
had contaminant levels below the detection
limit, the cord blood exposure levels were
coded in two levels: detected/undetected for
selected congeners, and above/below median
for summed variables. PCB-101 and PCB-128
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Table 1. Blood levels of hormones during pregnancy and at birth.
First trimester (n = 40) Second trimester (n = 147)a At delivery (n = 100) Cord blood (n = 92)
5th–95th 5th–95th 5th–95th 5th–95th
Median percentiles Median percentiles Median percentiles Median percentiles
TSH, mIU/L 2.1 0.09–9.55 2.2 0.62–5.5 2.6 0.8–7.53 9.8 3.4–30.4
fT4, pmol/L 14.3 11.5–18.7 12.8 10.2–15.8 11.6 8.7–15.05 16.1 12.8–19.6
TT3, nmol/L 2.7 1.97–3.6 3.2 2.3–4.2 3.3 2.4–4.5 1.3 0.9–1.9
mIU, milli-international unit.
aFor women who were sampled twice in the second trimester, only the second sample is included. as well as trans-chlordane, cis-chlordane, and
aldrin were excluded from statistical analysis
because 100% were undetected values.
THs are involved in lipid metabolism,
and the reduction in their circulating level in
hypothyroid subjects is associated with an
atherogenic lipid profile (Al Tonsi et al.
2004). Therefore, in order to take into con-
sideration the effects of THs on blood lipid
mobilization, analyses both adjusted and
unadjusted for lipid concentration were per-
formed. Two kinds of physiologic sequences
are possible in the tested relationship between
lipophilic contaminants such as PCBs or pes-
ticides, and THs: ﬁrst, the hypothesized rela-
tion that increased lipids lead to increased
blood PCBs, which lead to decreased TH lev-
els; and second, an inverse relation where
decreased THs lead to increased lipids, which
lead to increased blood PCBs. The compari-
son of two models, adjusted and not lipid-
adjusted, can indicate whether lipids are a
confounding factor in a hypothesized relation
or an intermediate factor in the inverse link.
The lipid concentration variables were intro-
duced in linear models as ﬁxed variables. The
criterion for signiﬁcance was set at p < 0.05.
In order to demonstrate the cumulative
effect of studied pollutants, we defined two
groups of subjects based on the degree of their
exposure to five OCs significantly related to
hormone levels: PCB-138, PCB-153, PCB-180,
p,p´-dichlorodiphenyldichloroethylene
(p,p´-DDE), and hexachlorobenzene. The
exposed group included women who had two
or more pollutant levels higher than the 75th
percentile of distribution, and the nonexposed
group included those with none or only one
pollutant level higher than the 75th percentile.
Results
Population characteristics. The women who
gave birth (n = 101) averaged 27 years of age
(range, 15–39 years); 30% smoked during
pregnancy, and 8% consumed alcohol moder-
ately (0.5–2 drinks/week, 4–30 g of alcohol/
week). During pregnancy, 11 women (10%)
had gestational diabetes, 2 of those with preg-
nancy-induced hypertension; 11 women had
pregnancy-induced hypertension without ges-
tational diabetes, 2 of those with proteinuria.
Five percent of births occurred before 37 weeks
of pregnancy, the average birth weight was
3.3 kg (range, 1.9–5.0 kg), and 51% of new-
borns were boys. The characteristics of women
lost to follow-up (n = 48) were not signiﬁcantly
different from those giving birth at participat-
ing maternity hospitals.
Hormone and contaminant levels during
pregnancy and at birth. The TH concentra-
tions are shown in Table 1, and Tables 2
and 3 present the blood PCB congener and
pesticide levels. We observed that TT3 and
TSH levels increased during pregnancy,
whereas fT4 levels decreased. TH levels in
this population of pregnant women are simi-
lar to data reported by de Escobar et al.
(2004). The cord blood PCB concentrations
were signiﬁcantly lower than maternal blood
and, in most samples, lower than detection
limit level.
In general, unadjusted blood PCB con-
gener concentrations appeared to increase
during pregnancy. However, when adjusted
for the increase of lipid mobilization during
pregnancy, concentrations were similar
throughout. In women with gestational dia-
betes, unadjusted PCB levels were signifi-
cantly higher at delivery than in nondiabetic
women, but when adjusted for lipid levels,
they were similar.
Exposure and hormonal status: cofactors
related to retained variables. The relationships
between variables of interest (maternal and
cord blood TSH, TT3, fT4, PCBs, pesticides,
and Hg concentrations) were tested with
respect to the following cofactors: maternal
age, gestational age at sampling, cigarette
smoking, alcohol use, birth weight, newborn’s
sex, and plasma total lipid contents. Maternal
age, gestational age at sampling, plasma total
lipid content, and cigarette smoking during
pregnancy were related to most maternal bio-
chemical measures (data not shown) and were
added in ﬁnal mixed models. For cord blood
measures, total lipid levels, maternal age, birth
weight, gestational age at birth, and cigarette
smoking during pregnancy were associated
with cord blood hormone levels and exposure
variables.
Relationships between TH levels and
plasma PCBs, pesticides, and Hg concentra-
tions in pregnant women. Table 4 presents
the results from mixed models including
TSH, fT4, and TT3 levels during pregnancy
in relation to plasma PCB concentrations. In
both lipid-adjusted and nonadjusted models,
only TT3 levels were strongly negatively
related to PCB concentrations, especially to
non-coplanar congeners (PCB-138, PCB-153,
and PCB-180). No relation was observed
with the sum of mono-ortho coplanar con-
geners (PCB-105, PCB-118, and PCB-156;
Σmono-ortho coplanar PCBs). PCB-180 was
Environmental pollutants and thyroid function
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Table 2. Concentrations of plasma PCB congeners (µg/L) shown as median (5th–95th percentiles) or per-
cent of samples above detection limit.
First trimester Second trimester At delivery Cord blood
Congener (n = 39) (n = 145) (n = 101) (n = 92)
PCB-28 10% 28% 21% 2%
PCB-52 0% 2% 4% 1%
PCB-99 0.02 (ND–0.05) 0.02 (ND–0.05) 0.02 (ND–0.06) 6%
PCB-101 0% 0% 0% 0%
PCB-105 3% 12% 23% 8%
PCB-118 0.02 (ND–0.08) 0.03 (ND–0.08) 0.03 (ND–0.10) 33%
PCB-128 0% 0% 0% 0%
PCB-138 0.06 (0.02–0.18) 0.07 (0.03–0.20) 0.08 (0.03–0.25) 0.02 (ND–0.06)
PCB-153 0.07 (0.03–0.26) 0.08 (0.03–0.27) 0.09 (0.04–0.30) 0.02 (ND–0.08)
PCB-156 0.02 (ND–0.05) 0.02 (ND–0.05) 0.02 (ND–0.07) 37%
PCB-170 0.01 (ND–0.07) 0.02 (ND–0.07) 0.02 (ND–0.07) 7%
PCB-180 0.04 (0.02–0.14) 0.05 (0.02–0.17) 0.05 (0.02–0.19) 0.01 (ND–0.05)
PCB-183 8% 15% 27% 1%
PCB-187 0.02 (ND–0.06) 0.02 (ND–0.05) 0.02 (ND–0.06) 14%
ΣMono-ortho coplanar PCBsa 0.06 (ND–0.14) 0.06 (ND–0.15) 0.07 (0.04–0.18) 0.04 (ND–0.07)
Total PCBs 0.33 (0.16–1.31) 0.35 (0.18–1.05) 0.39 (0.20–1.22) 0.16 (ND–0.35)
ND, nondetectable. 
aSum of PCB-105, PCB-118, and PCB-156. 
Table 3. Blood Hg and plasma pesticide concentrations (µg/L) shown as median (5th–95th percentiles) or
percent of samples above detection limit.
First trimester Second trimester At delivery  Cord blood 
(n = 39) (n = 145) (n = 101) (n = 92)
THg 0.80 (0.40–2.20) 0.60 (ND–2.0) 0.60 (ND–1.2) 0.60 (ND–1.6)
OHg 0.40 (ND–1.40) 0.20 (ND–1.20) 0.20 (ND–0.80) 0.30 (ND–1.30)
trans-Nanochlor 0.03 (ND–0.09) 0.04 (0.02–0.10) 0.05 (ND–0.15) 14%
Oxychlordane 0.02 (ND–0.06) 0.03 (0.02–0.07) 0.03 (0.02–0.08) 10%
Mirex 19% 15% 20% 1%
Hexachlorobenzene 0.04 (0.03–0.10) 0.06 (0.03–0.11) 0.06 (0.04–0.12) 0.02 (0.01–0.05)
DDT 0.01 (ND–0.04) 0.03 (ND–0.05) 0.04 (ND–0.07) 11%
p,p´-DDE 0.38 (0.16–0.90) 0.43 (0.22–0.97) 0.47 (0.20–1.20) 0.16 (0.08–0.40)
cis-Nanochlor 0% 1% 20% 0%
trans-Chlordane 0% 0% 0% 0%
cis-Chlordane 0% 0% 0% 0%
β-BHC 0.03 (ND–0.05) 0.04 (ND–0.08) 0.05 (ND–0.09) 1%
Aldrin 0% 0% 0% 0%
ND, nondetectable. positively correlated with TSH levels but not
with fT4 levels.
Concordant results were obtained when
the correlation with plasma pesticides was
examined. Hexachlorobenzene, cis-nanochlor,
and p,p´-DDE concentrations were negatively
related to TT3 levels in mothers in lipid-
adjusted models. Blood IHg was also nega-
tively related to TT3 levels (Table 5). In
addition, cis-nanochlor, when detected, was
positively correlated with fT4 levels.
Figure 1 illustrates the change of TT3 and
fT4 levels during pregnancy by group of expo-
sure to five pollutants that are significantly
related to TT3 levels in previous analyses
(PCB-138, PCB-153, PCB-180, p,p´-DDE,
and hexachlorobenzene). For the women in
the nonexposed group (none or one of these
pollutant levels higher than the 75th per-
centile of distribution), TT3 levels signiﬁcantly
increased from the second trimester to deliv-
ery; for the women from the exposed group
(two or more pollutant levels higher than the
75th percentile), TT3 levels decreased.
Moreover, this relationship was much more
significant than those in women classified
according to any OC level higher than 75th
percentile, separately (data not shown). 
Relationships between cord blood plasma
PCB, pesticide, and Hg concentrations and
cord blood hormone levels. In general, the
PCB congeners and pesticide residues in cord
plasma were not signiﬁcantly related to cord
blood THs (data not shown). The cord blood
OHg was not signiﬁcantly related to hormone
levels. Only cord blood IHg was negatively
related to fT4 level (adjusted mean, 16.5
pmol/L in subjects with undetected IHg vs.
15.5 pmol/L in those with detected values;
partial Spearman r = –0.26, p = 0.02).
Discussion
Our results demonstrate a signiﬁcant negative
relationship between circulating TT3 levels in
pregnant women at low environmental doses
of PCB-138, PCB-153, PCB-180, IHg, and
two pesticides, p,p´-DDE and hexachloro-
benzene. In addition, only cis-nanochlor, in
women having detected values, was related to
both increased fT4 and decreased TT3, during
pregnancy. No other significant relation was
observed in regard to fT4 or TSH levels. No
association was observed between cord blood
organic pollutant concentrations and TH lev-
els, except for the negative correlation between
IHg and fT4 in cord blood serum. The results
from the Dutch cohort study (Koopman-
Esseboom et al. 1994) show a decrease in
maternal T3 and T4 in pregnancy and in
infant TSH levels in relation to toxic equiva-
lents of milk PCB dioxin-like and non-
coplanar congeners. These authors also noted
that higher levels of maternal and cord blood
plasma PCB-118, PCB-138, PCB-153, and
PCB-180 correlated signiﬁcantly with higher
plasma TSH levels in infants in the second
week after birth. Higher levels of three non-
coplanar congeners (PCB-137, PCB-138, and
PCB-153) in human milk also correlated
signiﬁcantly with higher TSH levels in umbili-
cal blood plasma. In another study, which
investigated cord blood for TSH in relation to
the same congeners (PCB-118, PCB-138,
PCB-153, and PCB-180), no relation between
PCBs and TSH was found (Ribas-Fito et al.
2003), but other THs (T3, T4) were not mea-
sured. In a study on the effects of exposure to
methylmercury on thyroid function at birth,
Steuerwald et al. (2000) found no relation
with Hg levels, but cord blood resin-T3
uptake levels were negatively correlated with
the non-coplanar PCBs in maternal blood
samples. The lowering of resin-T3 uptake is
one indicator of primary or secondary hypo-
thyroidism. Thus, thyroid-binding globulin
(TBG) levels rose in cord blood with increased
maternal PCB exposure.
The lack of relationship in regard to cord
blood THs in our study could be related to
other biologic factors such as iodine and sele-
nium intake or circadian variation (Andersen
et al. 2003; Beckett et al. 2005), which are
likely to influence endogenous hormone
homeostasis, as well as to the very low level of
exposure in fetal tissues. Exposure levels to
PCB congeners in this population were
3–45 times lower than in previously reported
studies [reviewed by Longnecker et al. (2003)].
In addition, fetal TBG and other binding
proteins are low (Hume et al. 2004), which
could protect the fetus from toxic effects of
chemicals that act on TH binding. Also, thy-
roid status can be disrupted by other factors
not measured in the present study, including
environmental pollutants such as pentachloro-
phenol (PCP) or OH-PCBs, which are
metabolites of hexachlorobenzene and PCBs,
respectively, as was reported previously in
another Québec population (Sandau et al.
2002). These authors reported negative corre-
lations between cord plasma free T3 and T4, as
well as TBG, with sum of PCP and OH-PCBs
but not with PCB congeners individually or
ΣPCB. Curiously, the concentrations of PCBs
and OH-PCBs were also negatively correlated
with TSH in cord plasma. Although these cor-
relations were highly significant, they were
obtained from a small sample of newborns
(n = 20) without any adjustment for con-
founding variables.
Similar to the present results, the selective
effect of PCBs on T3 levels has been reported
in women who eat ﬁsh (Hagmar et al. 2001)
(n = 32); in that study, the PCB-153 concen-
tration was negatively related to TT3 levels.
Osius et al.’s (1999) study of schoolchildren
showed that PCB-138, PCB-153, and
PCB-180 levels were negatively related to free
T3 levels without any significant change in
TSH or T4 concentrations; this relationship
was significant only in girls. To our knowl-
edge, these are the only two studies that have
demonstrated a more pronounced effect on T3
than on T4. However, in physiologic and
pathologic conditions the isolated reduction
of T3 levels is rarely observed because there
are effective compensatory mechanisms via
T4 production.
The results of the present study indicate
that blood lipid content is not a major
confounding factor for the relationship
between THs and OCs. Both lipid-adjusted
and unadjusted models revealed the same
degree of signiﬁcance for OC exposure. Thus,
Takser et al.
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Table 4. Hormone levels and PCBs concentrations during pregnancy.
TSH (mIU/L) fT4 (pmol/L) TT3 (nmol/L)
Unadjusted Adjusteda Unadjusted Adjusteda Unadjusted Adjusteda
ΣPCB (µg/L)
Estimate 0.65 0.45 –0.08 0.49 –0.37 –0.47
df 151 148 151 148 151 148
Type 3 F-value 0.50 0.21 0.05 1.6 6.4* 9.6**
Σmono-ortho coplanar PCBsb (µg/L)
Estimate 3.0 0.46 –2.6 2.7 –1.3 –2.1
df 151 148 151 148 151 148
Type 3 F-value 0.13 0.0 0.60 0.62 0.98 2.27
PCB-138 (µg/L)
Estimate 0.90 –0.55 –0.48 3.1 –2.1 –2.8
df 151 148 151 148 151 148
Type 3 F-value 0.03 0.01 0.05 2.1 7.2** 11.2**
PCB-153 (µg/L)
Estimate –0.18 -0.93 0.57 2.5 –1.2 –1.5
df 151 148 151 148 151 148
Type 3 F-value 0.0 0.08 0.19 3.6 5.9* 8.6**
PCB-180 (µg/L)
Estimate 7.8 7.5 –1.4 -0.27 –1.2 –1.4
df 151 148 151 148 151 148
Type 3 F-value 5.3* 4.6* 1.1 0.04 6.0* 7.7**
df, degrees of freedom. Mixed model parameters for repeated measures adjusted for gestational age at sampling, mater-
nal age, and cigarette smoking during pregnancy. 
aAdjusted for total lipid concentrations. bSum of PCB-105, PCB-118, and PCB-156. *p < 0.05. **p < 0.01. the rise of lipids after the TH decrease is
unlikely to be an intermediate factor of the
observed relationships.
Although epidemiologic studies cannot
explore precise mechanisms of observed statis-
tical relationships, some mechanistic hypothe-
ses can be proposed. The deiodination
mechanism could be hypothesized to explain
observed decrease in T3 levels in relation to
exposure to OCs and Hg. As reviewed by
Bianco et al. (2002), the T3 degradation by
type 3 deiodinase (D3), which catalyzes the
inner ring deiodination of T4 to reverse T3
(rT3) and of T3 to 3,3´-T2, represents an
important pathway for the inactivation of
THs. D3 shows substrate preference for T3
over T4 and is expressed at high levels in
human placental tissue (Huang et al. 2003).
The overexpression of D3, called “consump-
tive hypothyroidism” and reported in infantile
hemangiomas, is characterized by undetectable
serum T4 and T3 and high rT3 levels. Our
results could be related to direct or indirect
induction of D3 activity or its increased expres-
sion, but we did not assess the free T3 or rT3
levels to confirm this hypothesis. This needs
further experimental research at low levels of
OC exposure. In addition, an increase in pla-
cental D3 activity in methylmercury-exposed
mice has been reported (Watanabe et al.
1999). Interestingly, the brain D3 activity was
depressed in the fetuses from exposed dams. In
our study, it is difﬁcult however to explain the
lack of association with cord serum T3 given
that placental D3 participates in fetal T3 degra-
dation in humans (Santini et al. 1999).
Other types of deiodinases present in dif-
ferent tissues can contribute to T4 and T3 deio-
dination. In humans, 80% of circulating T3,
the physiologically active form of TH, is gener-
ated from peripheral deiodination of T4 by
enzymatic action of 5´-monodeiodinase, and
20% is derived from thyroidal secretion (Pilo
et al. 1990). There are two types of 5´-mon-
odeiodinase enzyme: D1 is located at the
plasma membrane, and D2 is associated with
endoplasmic reticulum. The T3 generated by
D1 does not have direct access to nuclei but
instead must ﬁrst be exported into the plasma.
Both D1 and D2 deiodinases contribute to
plasma T3 content. The substrates for these
enzymes are rT3 and T3 sulfate for D1, and T4
and rT3 for D2 (Bianco et al. 2002). However,
serum T3 concentration remains normal in
D1- or D2-deﬁcient mice (Maia et al. 1995).
Several studies have explored the effect of
OCs on D1 and D2 deiodinase activity. One
study reported the depression of liver D1
activity in response to Aroclor 1242 and 1254
treatment in the chick embryo (Gould et al.
1999). Wade et al. (2002) examined the effect
of subchronic exposure to complex mixture of
persistent contaminants (16 OCs, lead, and
cadmium) on THs in male rats and reported
increased TSH levels at the lowest level of
exposure without any changes in T4 or T3.
Moreover, the authors observed significant
reduction in hepatic D1 activity and specu-
lated that the TSH increase could be related to
pituitary D2 depression. There is a need for
further investigations to explore the role of
deiodinases in toxicity of environmental pollu-
tants, such as PCBs and pesticides, in humans.
In addition to deiodination, TH is also
metabolized by conjugation of the phenolic
hydroxyl group with glucuronic acid or sulfate
(Leonard and Köhrle 1996). This mechanism
is also involved in OC toxicity. For example,
hexachlorobenzene was shown to decrease
total and fT4 levels in rats, without signiﬁcant
effect on T3 (Kleiman de Pisarev et al. 1990).
Hexachlorobenzene decreased kidney and
brown adipose tissue D1 activity after
15–21 days of exposure, but total body D1
activity was significantly increased. In addi-
tion, hexachlorobenzene increased the activity
of hepatic T4 UDPGT in a time-dependent
manner without changes in T3-UDPGT
(Alvarez et al. 2005). The same mechanism
on T4-UDPGT was proposed to explain the
decrease in T4 following PCB exposure
(Barter and Klaassen 1994). However, we did
not observe any negative association between
fT4 and OCs. Thus, we cannot consider an
effect on the enzyme responsible for TH con-
jugation as a possible explanation of these
results. We observed, however, a negative
relationship between fT4 in cord blood serum
and IHg. If this relationship was not due to
chance, it may be related to inducing proper-
ties of IHg on UDPGT in renal tissue
reported in mice (Tan et al. 1990). Moreover,
workplace exposure to IHg was reported to be
associated with increases in T4, rT3, and the
T4:T3 ratio (Ellingsen et al. 2000), suggesting
an inhibitory effect of Hg on deiodinase activ-
ity. In our study, IHg was associated with a
Environmental pollutants and thyroid function
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Figure 1. Change in TT3 (nM) and fT4 (pM) levels
between second trimester and delivery in pregnant
women by group of exposure, adjusted to gesta-
tional age at sampling. p = 0.006 for TT3 but fT4 was
not statistically signiﬁcant.
Table 5. Hormone levels, Hg, and pesticides concentrations during pregnancy.
TSH (mIU/L) fT4 (pmol/L) TT3 (nmol/L)
Unadjusted Adjusteda Unadjusted Adjusteda Unadjusted Adjusteda
OHg (µg/L)
Estimate 0.58 — –0.18 — 0.05 —
Type 3 F-value 0.50 — 0.34 — 0.18 —
IHg (µg/L)
Estimate –0.41 — –0.26 — –0.27 —
Type 3 F-value 0.28 — 0.57 — 4.20* —
trans-Nanochlor (µg/L)
Estimate –0.66 –1.9 –5.3 –1.65 –0.50 –0.91
Type 3 F-value 0.01 0.09 3.80 0.40 0.20 0.80
Oxychlordane (µg/L)
Estimate 10.3 4.6 –7.8 3.9 –4.1 –4.6
Type 3 F-value 0.46 0.08 1.53 0.37 2.96 3.15
Mirex, detected vs. undetected
Estimate 0.09 0.03 –0.11 0.13 0.07 0.08
Type 3 F-value 0.01 0.0 0.14 0.19 0.36 0.41
Hexachlorobenzene (µg/L)
Estimate –5.4 –11.0 –2.3 8.1 –3.4 –5.2
Type 3 F-value 0.20 0.82 0.20 2.91 3.83 7.51**
DDT (µg/L)
Estimate –8.5 –14.2 –0.89 9.9 1.39 0.26
Type 3 F-value 0.3 0.8 0.02 2.8 0.4 0.01
p,p´-DDE (µg/L)
Estimate 0.25 –0.06 –0.75 0.09 –0.37 –0.54
Type 3 F-value 0.04 0.0 2.0 0.03 3.3 6.1*
cis-Nanochlor, detected vs. undetected
Estimate 0.67 0.41 0.33 0.74 –0.34 –0.35
Type 3 F-value 0.36 0.13 0.73 3.92 5.33* 5.40*
β-BHC (µg/L)
Estimate –2.1 –5.4 2.3 8.8 –2.4 –3.4
Type 3 F-value 0.04 0.2 0.3 4.2* 2.0 3.8
aAdjustment for total lipid concentrations: mixed model parameters for repeated measures adjusted for gestational age
at sampling, maternal age, and cigarette smoking during pregnancy [degrees of freedom (df) = 151 for unadjusted and
df = 148 for adjusted analyses]. *p < 0.05. **p < 0.01.decrease in maternal TT3 during pregnancy
that could be due to an effect of Hg on deiodi-
nase activity. However, because the fT4 levels
were not changed and free T3 was not deter-
mined, this explanation remains speculative.
Binding to TBG and/or to transthyretin,
two major TH transporters in blood, could be
proposed as an alternative hypothesis to
explain the observed negative relationship
between OCs and TT3 levels during preg-
nancy. PCBs, especially non-coplanar con-
geners, bear a structural resemblance to the
endogenous THs and have a high afﬁnity for
TH-binding proteins such as transthyretin
(Chauhan et al. 2000). Also, hydroxylated
PCB metabolites bound to transthyretin with
afﬁnities similar to that of T4, but they have a
low affinity for TBG (Cheek et al. 1999).
Alteration of TH-binding capacity in serum is
associated with variations in total TH concen-
tration. Diminished serum TH values are
observed in subjects with TBG deficiency.
However, decreased concentration or afﬁnity
of transthyretin is not associated with varia-
tions in serum concentrations of THs
(Bartalena and Robbins 1992). Few data are
available about affinities of PCBs and pesti-
cides to bind to TBG.
There are substantial and important differ-
ences between humans and animals with
respect to structural characteristics of deiodi-
nase enzyme and thyroid economy. In both
rodents and humans, deiodinases are seleno-
cysteine-containing proteins, and the presence
of selenocysteine in the protein is critical for
enzyme activity. However, the carboxy termi-
nal of D1 from rat liver was different from
that of other species (Santini et al. 1992).
Also, the rat has a much larger contribution of
T3 secreted directly from the thyroid gland
than humans. It has been estimated that only
approximately 20% of plasma T3 in humans
comes from thyroidal secretion, as opposed to
about 40% in rats (Bianco et al. 2002). It has
also been estimated that D1 catalyzes about
half of the daily extrathyroidal T3 production
from T4 in the rat versus an estimate of 25%
in humans (Bianco et al. 2002). There is also
heterogeneity in the transport of THs between
species. In humans, THs are primarily bound
to TBG. The remainder is bound to less-
speciﬁc proteins, such as albumin and trans-
thyretin. These three proteins transport more
than 95% of THs (Barlow 1997; Bartalena
and Robbins 1992). In growing rats, a signiﬁ-
cant difference is that TBG is not found
between 2 and 7 months of age, the age range
typically used in basic toxicology studies
(Vranckx et al. 1994). In adult rats, THs are
bound to the low-afﬁnity carriers albumin and
transthyretin. As a consequence, the half-life
of THs is shorter in adult rats than in humans
(McClain 1995). These various interspecies
differences imply a different predisposition of
rats compared with humans to perturbations
of thyroid homeostasis by chemicals that inﬂu-
ence thyroid status (Lans et al. 1994).
One limitation of our study is the meas-
ure of TT3 and fT4 without free T3 and total
T4 levels. The TT3 does not include rT3 and
T3 sulfate levels, which could help us to con-
ﬁrm the hypothesis that PCB, pesticides, and
Hg affect T4 or T3 deiodination. Also, we are
unable to show if the observed relationship is
related to free T3 decrease or to T3 fraction
binding to TBG. Moreover, it is difficult to
distinguish the proper effect of each OC on
THs because of their high collinearity (corre-
lations between OCs > 0.60). However, their
cumulative or synergistic effects can not be
excluded considering the most important
decrease of TT3 when it is correlated with
more than one OC.
Thyroid status is frequently assessed dur-
ing pregnancy but limited routinely to
measurements of TSH. Few data exist on the
role of physiologic changes in thyroid status in
pregnant women and the effect of subtle T3
and T4 variations on women’s health. One
study suggests that low free T3 levels are asso-
ciated with postpartum depression syndrome
(Ijuin et al. 1998), but further investigations
are needed to evaluate the long-term conse-
quences of subtle thyroid changes related to
environmental exposure to persistent organic
contaminants. In conclusion, the potential of
low-dose exposure to OC mixtures to interfere
with hormonal status during pregnancy war-
rants further investigations with complete
assessment of thyroid status to confirm our
results and to determine the short- and long-
term consequences of these disturbances.
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